印日韩传统医药海外发展政策分析及启示

近年来,各国愈发重视本国传统医药的传承与海外发展,中国、印度、日本、韩国作为传统医药文明大国,在传统医药海外发展方面具有一定领先性,四国均已出台具有指导意义的纲领性文件和政策,如《中医药发展战略规划纲要(2016-2030年)》《AYUSH国际合作提升计划》《日本全球卫生外交策略》《韩医药发展五年综合计划》.本文通过分析印、日、韩传统医药海外发展情况,总结和借鉴其政策特点,为我国的中医药海外发展提出建议.

In recent years,more importance has been increasingly attached to the inheritance and overseas development of traditional medicine.China,India,Japan,South Korea,who owns traditional medicine civilization,have certain leadership in overseas development aspect.The four countries have introduced several related policies and have guiding significance to the programmatic document,such as the Development Strategy of Traditional Chinese Medicine Outline(2016-2030),Central Sector Scheme for Promotion of International Co-operation in AYUSH,Japan global health diplomacy,Five-year Plan Development of Korean medicine.This paper analyzes the overseas development of Traditional Medicine in India,Japan and South Korea,summarizes and draws lessons from their policy characteristics,and puts forward suggestions for the overseas development of Traditional Chinese Medicine in terms of policies,organizational security,personnel training,cultural industry and scientific and technological innovation.